全文获取类型
收费全文 | 78篇 |
免费 | 0篇 |
国内免费 | 6篇 |
专业分类
儿科学 | 3篇 |
妇产科学 | 2篇 |
基础医学 | 12篇 |
临床医学 | 13篇 |
内科学 | 16篇 |
神经病学 | 1篇 |
外科学 | 2篇 |
预防医学 | 3篇 |
药学 | 29篇 |
中国医学 | 3篇 |
出版年
2021年 | 1篇 |
2020年 | 8篇 |
2019年 | 3篇 |
2018年 | 4篇 |
2016年 | 2篇 |
2015年 | 7篇 |
2014年 | 4篇 |
2013年 | 8篇 |
2012年 | 5篇 |
2011年 | 6篇 |
2010年 | 8篇 |
2009年 | 6篇 |
2008年 | 5篇 |
2007年 | 3篇 |
2006年 | 5篇 |
2005年 | 2篇 |
2004年 | 1篇 |
2002年 | 2篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 1篇 |
排序方式: 共有84条查询结果,搜索用时 46 毫秒
31.
OBJECTIVE: This meta-analysis of controlled clinical trials was conducted to evaluate whether the use of broad-spectrum antibacterial therapy is associated with improvement in the clinical symptoms of Crohn's disease (CD). METHODS: The MEDLINE and SCOPUS databases were searched from 1966 through May 3, 2006, for clinical trials that evaluated the efficacy of broad-spectrum antibiotics in CD. The search terms were Crohn's disease and antibiotics, antimicrobial, metronidazole, ciprofloxacin, or cotrimoxazole. The reference lists of retrieved articles were reviewed for additional relevant studies. Clinical improvement (response, remission, or improvement in clinical and/or laboratory findings) was the key outcome of interest. RESULTS: Six randomized, placebo-controlled clinical trials were included in the meta-analysis. Pooling of the results from these trials yielded an odds ratio of 2.257 (95% CI, 1.678-3.036; P < 0.001) for antimicrobial therapy compared with placebo in patients with CD. CONCLUSION: The results of this meta-analysis suggest that broad-spectrum antibiotics improve clinical outcomes in patients with CD, although further trials are needed. 相似文献
32.
Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized,Controlled Trials 总被引:3,自引:0,他引:3
Nikfar S Rahimi R Rahimi F Derakhshani S Abdollahi M 《Diseases of the colon and rectum》2008,51(12):1775-1780
Purpose This study was designed to evaluate whether probiotics improve symptoms in patients with irritable bowel syndrome.
Methods PubMed, Embase, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched for studies that
investigated the efficacy of probiotics in the management of irritable bowel syndrome. Clinical improvement was the key outcome
of interest. Data were searched within the time period of 1966 through September 2007.
Results Eight randomized, placebo-controlled, clinical trials met our criteria and were included in the analysis. Pooling of eight
trials for the outcome of clinical improvement yielded a significant relative risk of 1.22 (95 percent confidence interval,
1.07–1.4; P = 0.0042).
Conclusions Probiotics may improve symptoms of irritable bowel syndrome and can be used as supplement to standard therapy. 相似文献
33.
Inhaled corticosteroids (ICs) are the drug of choice for asthmatic women during pregnancy, but the results on the effects of these medications on obstetrical and perinatal outcomes are not conclusive. Meta-analysis is the statistical analysis of a collection of analysis results from individual studies for the purpose of integrating the findings. Meta-analysis techniques are necessary because only summary statistics are available in the literature. In order to determine the risk of exposure to ICs, we pooled data from all clinical studies that evaluated the pregnancy and perinatal outcomes in women exposed to this group of drugs during pregnancy by the meta-analytic technique. PUBMED, OVID, EMBASE and SCOPUS databases were searched for studies that investigated birth outcome following exposure to ICs during pregnancy. Data were collected from 1997 to 2005 (up to 31 December). Types of outcome investigated were major malformations, preterm delivery, low birth weight and pregnancy-induced hypertension. The criteria for inclusion of studies in this meta-analysis were exposure of women to any therapeutic dosage of any ICs (fluticasone, beclomethasone, budesonide, triamcinolone and flunisolide) during pregnancy. The results showed that ICs do not increase the risk of major malformations, preterm delivery, low birth weight and pregnancy-induced hypertension. In conclusion, ICs do not increase the rates of any obstetrical outcomes investigated in the present study and interestingly improve the symptoms and are helpful in the management of asthma and thus can be used comfortably during pregnancy. 相似文献
34.
Roja Rahimi Shekoufeh Nikfar Ali Rezaie Mohammad Abdollahi 《World journal of gastroenterology : WJG》2009,15(13):1548-1553
We aimed to evaluate the efficacy of tricyclic antidepressants (TCAs) as a therapeutic option for irritable bowel syndrome (IBS) through meta-analysis of randomized controlled trials. For the years 1966 until September 2008, PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched for double-blind, placebo-controlled trials investigating the efficacy of TCAs in the management of IBS. Seven randomized, placebo-controlled clinical trials met our criteria and were included in the meta- analysis. TCAs used in the treatment arm of these trials included amitriptyline, imipramine, desipramine, doxepin and trimipramine. The pooled relative risk for clinical improvement with TCA therapy was 1.93 (95% CI: 1.44 to 2.6, P 〈 0.0001). Effect size of TCAs versus placebo for mean change in abdominal pain score among the two studies was -44.15 (95% CI: -53.27 to -35.04, P 〈 0.0001). It is concluded that low dose TCAs exhibit clinically and statistically significant control of IBS symptoms. 相似文献
35.
Pooneh Salari Sharif Shekoufeh Nikfar Mohammad Abdollahi 《Age (Dordrecht, Netherlands)》2011,33(3):421-431
Phytoestrogens as selective estrogen receptor modulators like compounds may consider as a therapeutic option in osteoporosis.
In this regard, the effect of phytoestrogens on bone biomarkers was examined in several trials which their results are controversial.
We aimed this meta-analysis to evaluate the net effect of phytoestrogens on bone markers. A thorough search was conducted
from 2000 to 2010 in English articles. All randomized clinical trials were reviewed, and finally, 11 eligible randomized clinical
trials were selected for meta-analysis. Totally 1,252 postmenopausal women were enrolled in the study by considering the changes
of pyridinoline (Pyd), desoxypyridinoline (Dpyd), bone alkaline phosphatase, and osteocalcin concentrations in urine and serum
after phytoestrogens consumption. The urine Pyd and Dpyd levels decreased significantly in phytoestrogens consumers. Effect
size and effect size for weighted mean difference of urine Pyd levels showed −1.229171 (95% confidence interval (CI) = −1.927639
to −0.530703) and −9.780623 (95% CI = −14.240401 to −5.320845), respectively, a significant results in comparison to control
group and significant results for Dpyd −0.520132 (95% CI = −0.871988 to −0.168275) and −0.818582 (95% CI = −1.247758 to −0.389407),
respectively. Meta-analysis indicates that phytoestrogens intake can prevent bone resorption, but its benefits on bone formation
are not significant. This favorable effect was observed in low doses and in at least 3 weeks of phytoestrogens intake. 相似文献
36.
Shekoufeh Nikfar Abbas Kebriaeezadeh Rassoul Dinarvand Mohammad Abdollahi Mohammad-Ali Sahraian David Henry Ali Akbari Sari 《Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences》2013,21(1):50
Background
Multiple sclerosis (MS) is a highly debilitating immune mediated disorder and the second most common cause of neurological disability in young and middle-aged adults. Iran is amongst high MS prevalence countries (50/100,000). Economic burden of MS is a topic of important deliberation in economic evaluations study. Therefore determining of cost-effectiveness interferon beta (INF β) and their copied biopharmaceuticals (CBPs) and biosimilars products is significant issue for assessment of affordability in Lower-middle-income countries (LMICs).Methods
A literature-based Markov model was developed to assess the cost-effectiveness of three INF βs products compared with placebo for managing a hypothetical cohort of patients diagnosed with relapsing remitting MS (RRMS) in Iran from a societal perspective. Health states were based on the Kurtzke Expanded Disability Status Scale (EDSS). Disease progression transition probabilities for symptom management and INF β therapies were obtained from natural history studies and multicenter randomized controlled trials and their long term follow up for RRMS and secondary progressive MS (SPMS). A cross sectional study has been developed to evaluate cost and utility. Transitions among health states occurred in 2-years cycles for fifteen cycles and switching to other therapies was allowed. Calculations of costs and utilities were established by attachment of decision trees to the overall model. The incremental cost effectiveness ratio (ICER) of cost/quality adjusted life year (QALY) for all available INF β products (brands, biosimilars and CBPs) were considered. Both costs and utilities were discounted. Sensitivity analyses were done to assess robustness of model.Results
ICER for Avonex, Rebif and Betaferon was 18712, 11832, 15768 US Dollars ($) respectively when utility attained from literature review has been considered. ICER for available CBPs and biosimilars in Iran was $847, $6964 and $11913.Conclusions
The Markov pharmacoeconomics model determined that according to suggested threshold for developing countries by world health organization, all brand INF β products are cost effective in Iran except Avonex. The best strategy among INF β therapies is CBP intramuscular INF β-1a (Cinnovex). Results showed that a policy of encouraging accessibility to CBPs and biosimilars could make even high technology products cost-effective in LMICs. 相似文献37.
Introduction: Irritable bowel syndrome (IBS) is a common chronic gastrointestinal (GI) tract disorder with significant disability and a considerable financial burden to health service due to the consumption of resources including investigations, physician time, and cost of treatment. Despite availability of multiple treatment options, there is still poor functional recovery. Areas covered: Probiotics has been investigated as a promising treatment for IBS, and have demonstrated beneficial effects in some patients. There are many clinical trials investigating the therapeutic benefits of probiotics in IBS but most of them are heterogenic in terms of dose or species used and clinical endpoints. However, recent major meta-analyses revealed benefits of probiotics in patients with IBS. Inhibition of binding of pathogenic bacteria to intestinal epithelial cells, enhancing barrier function of intestinal epithelial, acidification of the colon, suppression of the growth of pathogens, modulation of immunity, inhibition of visceral hypersensitivity, alteration in mucosal response to stress, and improvement of bowel dysmotility are among mechanisms that probiotics may act. Most commonly used probiotics come from the genera Bifidobacterium and Lactobacillus but other species are in trial. Expert opinion: Although further studies are still needed, current evidences are almost enough to convince experts that probiotics are efficient in the treatment of IBS. 相似文献
38.
Roya Nikfar Ghamartaj Khotaee Nematolah Ataee Sedigheh Shams 《Pediatrics international》2010,52(2):196-198
Background: Urinary tract infection (UTI) is a common problem in children. The aim of this study was to determine the usefulness of the procalcitonin (PCT) rapid test in the diagnosis of renal involvement in children with urinary tract infection. Methods: Through a case series study, PCT and C‐reactive protein rapid tests were measured in children with proven UTI at the Tehran Children's Medical Center, Iran. One‐hundred patients aged 1 month–14 years old (19 boys and 81 girls) with documented UTI were enrolled in the study. Results: Of 100 children, 62 patients (62%) had renal involvement on the basis of abnormal Tc‐dimercaptosuccinic acid scintigraphy and 38 patients (38%) had infection restricted to the lower urinary tract. There were no differences related to age or gender among the groups. The sensitivity and specificity of PCT were 77% and 89%, respectively, in prediction of renal involvement, whereas C‐reactive protein had a sensitivity of 80% and a specificity of 65%. Conclusion: We concluded that a rapid determination of PCT concentration could be useful for the management of children with febrile UTI in the emergency room. 相似文献
39.
A Meta-Analysis on the Efficacy of Probiotics for Maintenance of Remission and Prevention of Clinical and Endoscopic Relapse in Crohn’s Disease 总被引:2,自引:0,他引:2
Rahimi R Nikfar S Rahimi F Elahi B Derakhshani S Vafaie M Abdollahi M 《Digestive diseases and sciences》2008,53(9):2524-2531
OBJECTIVE: To evaluate whether probiotics maintain remission in patients with Crohn's disease (CD). DESIGN: A meta-analysis of controlled clinical trials. METHODS: PUBMED and Cochrane Central Register of Controlled Trials were searched for clinical trial studies investigated the efficacy of probiotics for the maintenance of remission in Crohn's disease. Clinical relapse and endoscopic relapse were the key outcomes of interest. Data were searched within the time period of 1966 through May 2007. RESULT: Eight randomized placebo-controlled clinical trials met our criteria and were included in the analysis. Seven determined clinical relapse and three evaluated endoscopic relapse among patients with CD received probiotics for maintenance of remission. Pooling of seven trials for the outcome of clinical relapse yielded an odds ratio of 0.92 (95% confidence interval of 0.52-1.62, P = 0.8853), a nonsignificant odds ratio. The odds ratio for three studies for the outcome of endoscopic relapse was 0.97 (95% confidence interval of 0.54-1.78, P = 0.93), a nonsignificant odds ratio. CONCLUSION: This meta-analysis fails to demonstrate the efficacy of probiotics in maintaining remission and preventing clinical and endoscopic recurrence in CD. It is suggested to use probiotic preparations containing a mixture of lactobacillus with E. coli or Saccharomyces. 相似文献
40.
Yusuf Ghasemi Manoochehr Makvandi Ali Reza Samarbafzadeh Ahmad Nejati Saeed Najafifard Niloofar Neisi Mojtaba Rasti Kambiz Ahmadi Ahmad Shamsizadeh Roya Nikfar 《Indian journal of pediatrics》2014,81(7):639-643